Wall Street analysts expect that HMS Holdings Corp (NASDAQ:HMSY) will report sales of $136.32 million for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for HMS’s earnings, with the highest sales estimate coming in at $137.70 million and the lowest estimate coming in at $135.59 million. HMS reported sales of $128.09 million in the same quarter last year, which suggests a positive year over year growth rate of 6.4%. The business is scheduled to report its next quarterly earnings results before the market opens on Friday, February 23rd.
According to Zacks, analysts expect that HMS will report full year sales of $136.32 million for the current year, with estimates ranging from $508.31 million to $510.42 million. For the next financial year, analysts expect that the business will post sales of $557.46 million per share, with estimates ranging from $550.42 million to $568.50 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that follow HMS.
A number of research firms have recently issued reports on HMSY. Wells Fargo & Co restated an “outperform” rating and issued a $20.00 price target (down from $25.50) on shares of HMS in a research report on Wednesday, November 29th. Canaccord Genuity dropped their price target on HMS from $22.00 to $17.00 and set a “buy” rating for the company in a research report on Monday, November 6th. Jefferies Group restated a “neutral” rating on shares of HMS in a research report on Sunday, November 5th. Cantor Fitzgerald restated a “hold” rating and issued a $16.00 price target on shares of HMS in a research report on Sunday, November 19th. Finally, Robert W. Baird restated a “buy” rating on shares of HMS in a research report on Sunday, November 19th. One analyst has rated the stock with a sell rating, five have given a hold rating, four have given a buy rating and two have issued a strong buy rating to the company. HMS currently has a consensus rating of “Buy” and a consensus price target of $20.39.
HMS (NASDAQ HMSY) opened at $15.06 on Wednesday. HMS has a fifty-two week low of $11.01 and a fifty-two week high of $20.90. The company has a market capitalization of $1,300.77, a P/E ratio of 51.93, a price-to-earnings-growth ratio of 2.27 and a beta of 0.84.
HMS declared that its Board of Directors has authorized a stock repurchase program on Friday, November 3rd that allows the company to repurchase $50.00 million in shares. This repurchase authorization allows the business services provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its stock is undervalued.
HMS Holdings Corp. is a holding company. The Company, through its subsidiaries, operates in the United States healthcare insurance benefit cost containment marketplace. It provides coordination of benefits services to government, and private healthcare payers and sponsors. Its payment integrity services ensure that healthcare claims billed are accurate and appropriate.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.